National Cancer Institute researchers have successfully reversed a woman's metastatic colon cancer using a new therapy, according to The Wall Street Journal.
Here's what you need to know:
1. At present, only one patient has been treated using this therapy; however, the researchers estimate that tens of thousands of patients could be eligible for this treatment each year.
2. The therapy uses a patient's own immune cells for a personalized treatment.
3. The therapy targets a genetic mutation known as KRAS G12D, which is related to gastrointestinal cancers.
4. This mutated gene causes roughly 90 percent of often lethal pancreatic cancers and 45 percent of colorectal cancers.
5. Eventually, the researchers believe this type of immunotherapy may be applicable to many cancer types.